Dr. Ryan Zarychanski, MD
Claim this profileSt. Boniface Hospital
Affiliated Hospitals
St Boniface Hospital
Health Sciences Centre Winnipeg
Clinical Trials Ryan Zarychanski, MD is currently running
Multiple Treatments
for Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
Recruiting
3 awards
Phase 3
3 criteria
Albumin
for Acute Kidney Injury
Study objectives: To determine whether, in critically ill patients with Acute Kidney Injury requiring renal replacement therapy (AKI-RRT), randomization to receive intravenous hyperoncotic albumin 20-25% (100 mL X two doses) compared to control/placebo normal saline boluses (100 mL X two doses) given during RRT sessions, leads to: 1. An increase in organ support-free days (primary outcome) at 28 days following randomization; and 2. An increase in RRT-free days (principal secondary outcome) at 28 days following randomization.
Recruiting
2 awards
Phase 4
4 criteria
More about Ryan Zarychanski, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ryan Zarychanski, MD has experience with
- Placebo
- Pantoprazole
- Placebo (0.9% Saline)
- Amoxicillin-clavulanate
- Anakinra
- Angiotensin Converting Enzyme Inhibitor
Breakdown of trials Ryan Zarychanski, MD has run
Gastrointestinal Bleeding
Upper GI Bleed
Coronavirus
Pneumonia
Community-acquired Pneumonia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan Zarychanski, MD specialize in?
Ryan Zarychanski, MD focuses on Gastrointestinal Bleeding and Upper GI Bleed. In particular, much of their work with Gastrointestinal Bleeding has involved treating patients, or patients who are undergoing treatment.
Is Ryan Zarychanski, MD currently recruiting for clinical trials?
Yes, Ryan Zarychanski, MD is currently recruiting for 2 clinical trials in Winnipeg Manitoba. If you're interested in participating, you should apply.
Are there any treatments that Ryan Zarychanski, MD has studied deeply?
Yes, Ryan Zarychanski, MD has studied treatments such as Placebo, Pantoprazole, Placebo (0.9% saline).
What is the best way to schedule an appointment with Ryan Zarychanski, MD?
Apply for one of the trials that Ryan Zarychanski, MD is conducting.
What is the office address of Ryan Zarychanski, MD?
The office of Ryan Zarychanski, MD is located at: St. Boniface Hospital, Winnipeg, Manitoba R2H 2A6 Canada. This is the address for their practice at the St. Boniface Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.